DRAGON Score for Post-TPA Stroke Outcome
ورودیهای بالینی بیمار
حداقل ۱۸ — حداکثر ۱۲۰ • واحد: years
حداقل ۵۰ — حداکثر ۸۰۰ • واحد: mg/dL
حداقل ۰ — حداکثر ۴۸۰ • واحد: minutes
حداقل ۰ — حداکثر ۴۲
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Excellent Prognosis0–1
- Good Prognosis2–2
- Moderate Prognosis3–3
- Poor Prognosis4–7
The DRAGON Score for Post-TPA Stroke Outcome calculator is designed for bedside predicting 3-month outcome (functional independence vs dependency) in ischemic stroke patients treated with tissue plasminogen activator (tPA) in clinical practice. The resulting score directly guides clinician decision-making regarding initiating intravenous thrombolysis, activating endovascular.
Clinical Guidelines & Evidence
Predicts 3-month outcome (functional independence vs dependency) in ischemic stroke patients treated with tissue plasminogen activator (tPA). Helps identify patients who may benefit from additional therapeutic interventions.
Clinical Indication
The DRAGON Score for Post-TPA Stroke Outcome is indicated for bedside clinical practice to support Predicts 3-month outcome (functional independence vs dependency) in ischemic stroke patients treated with tissue plasminogen activator (tPA). Helps identify patients who may benefit from additional therapeutic interventions.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with acute neurological deficits, acute ischemic stroke, intracranial hemorrhage, seizures, or altered mental status. Clinical application is indicated across Comprehensive stroke centers, acute neurovascular units, neuro-ICU, and emergency neurology services.
Limitations & Contraindications
Stroke mimics including severe hypoglycemia, Todd postictal paresis, and hemiplegic migraine must be ruled out prior to intravenous thrombolysis.
Clinical Pearls & Action Plan
Time is brain; rapid determination of Last Known Well time and baseline functional status dictates reperfusion eligibility. Guideline pearl: AUC-ROC consistently around 0.84 in validation studies.
DRAGON Score = D (Dense artery/early infarct: 0-2) + R (mRS >1: 0-1) + A (Age: 0-2) + G (Glucose >144 mg/dL: 0-1) + O (Onset >90 min: 0-1) + N (NIHSS: 0-3)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| hyperdense_artery_infarct | string | Yes | Hyperdense cerebral artery sign or early infarct signs on admission CT scan |
| prestroke_mrs | string | Yes | Pre-stroke modified Rankin Scale (mRS) score greater than 1 |
| age | integer | Yes | Patient age in years(years) |
| glucose | float | Yes | Baseline glucose level(mg/dL) |
| onset_to_treatment | integer | Yes | Time from symptom onset to treatment initiation(minutes) |
| nihss | integer | Yes | Baseline National Institutes of Health Stroke Scale (NIHSS) score |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–1 | Excellent Prognosis | Very low risk |
| 2–2 | Good Prognosis | Low risk |
| 3–3 | Moderate Prognosis | Moderate risk |
| 4–7 | Poor Prognosis | High risk |
| 8–8 | Very Poor Prognosis | Very high risk |
| 9–10 | Miserable Prognosis | Extremely high risk |
Evidence-Based References (EBM)
- Strbian D, Meretoja A, Ahlhelm FJ, et al. Predicting outcome of IV thrombolysis-treated ischemic stroke patients: the DRAGON score. Neurology. 2012;78(6):427-432. doi: 10.1212/WNL.0b013e318245d2a9.DOI: 10.1212/WNL.0b013e318245d2a9
- Turc G, Maïer B, Naggara O, et al. Clinical scales do not reliably identify acute ischemic stroke patients with large-artery occlusion. Stroke. 2016;47(6):1466-1472. doi: 10.1161/STROKEAHA.115.011336.DOI: 10.1161/STROKEAHA.115.011336
- Saposnik G, Guzik AK, Reeves M, et al. Stroke Prognosis Assessment Scale (SPAS) to predict mortality and functional outcome. Stroke. 2014;45(7):2018-2024. doi: 10.1161/STROKEAHA.114.004667.DOI: 10.1161/STROKEAHA.114.004667